Tonmya Tablet, Orally Disintegrating
NDC Package 70792-102-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tonmya (cyclobenzaprine hydrochloride) tablets is tONMYA™ is indicated for treatment of fibromyalgia in adults. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Tonix Medicines, Inc., this product is identified by NDC 70792-102 and is authorized under FDA application NDA219428.

Identification & Billing

NDC Package Code
70792-102-30
Package Description
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
Product Code
70792-102
11-Digit Billing Format
70792010230
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
  • RxCUI: 2723106 - cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet
  • RxCUI: 2723106 - cyclobenzaprine hydrochloride 2.8 MG (equivalent to cyclobenzaprine 2.47 MG) Sublingual Tablet
  • RxCUI: 2723114 - Tonmya 2.8 MG Sublingual Tablet
  • RxCUI: 2723114 - cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet [Tonmya]
  • RxCUI: 2723114 - Tonmya 2.8 MG (equivalent to cyclobenzaprine 2.47 MG) Sublingual Tablet

Clinical Specifications

Proprietary Name
Tonmya
Non-Proprietary Name
Cyclobenzaprine Hydrochloride
Substance Name
Cyclobenzaprine Hydrochloride
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Sublingual - Administration beneath the tongue.
Active Ingredient(s)
CYCLOBENZAPRINE HYDROCHLORIDE 2.8 mg/1
Pharmacologic Class
Usage Information
TONMYA™ is indicated for treatment of fibromyalgia in adults.

Regulatory & Marketing

Labeler Name
Tonix Medicines, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA219428
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70792-102). Click a package code to view its specific billing and regulatory data.

70792-102-14
14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
70792-102-60
60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
70792-102-90
90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70792-102-30 identifies a specific commercial package of 30 tablet, orally disintegrating in 1 bottle of Tonmya, a human prescription drug labeled by Tonix Medicines, Inc.. This tablet, orally disintegrating is formulated for sublingual use and contains cyclobenzaprine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Tonix Medicines, Inc. on August 15, 2025. The current certification is valid through December 31, 2026.

How is this Tonix Medicines, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70792010230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70792-102-30
11-Digit CMS (5-4-2)
70792-0102-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.